|
FDA Cancer Imaging Program (CIP) Bi-annual Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
This collaboration is a bi-annual meeting to enhance communication between the Cancer Imaging Program (CIP) and the Division of Medical Imaging Products of the Center for Drug Evaluation and Research (CDER) in the Food and Drug Administration (FDA). This allows for a two-way exchange of information and discussion of issues that are important for each side. Topics that have been discussed include CIP's standardization efforts of medical imaging scanners in the National Cancer Institute's (NCI) Cancer Centers, presentation and discussion of specific new molecular imaging modalities, and discussion of recent FDA decisions regarding new medical imaging innovations.
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
CC
|
The group is working on research that might gauge the effectiveness of psilocybin for pain management and use in other facets of palliative care.
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the Food and Drug Administration (FDA) for drug approval.
|
|
FDA Risk Evaluations and Midigation workshop (FDA REMS)
|
Meeting/ Workshop
|
FDA
|
OD/DPCPSI/ORWH
|
Participated as panelist in the Risk Evaluation and Mitigation Strategy (REMS) workshop in December. REMS is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks. This workshop was on opioids and pain.
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
The National Library of Medicine (NLM) and the Food and Drug Administration (FDA) established a collaborative effort to provide an interface for public access to the FDA’s Substance Registration System (SRS). The FDA SRS utilizes an existing NLM database backend architecture to provide public search capability for FDA substances and medicinal products.
|
|
FDA Uterine Fibroids Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, OD/DPCPSI/ORWH
|
The Uterine Fibroids Working Group is one working group of the Women’s Health Clinical Research Network (WH-CRN) that focuses specifically on the treatment of fibroids. The WH-CRN seeks to meet the growing demand for evidence that better reflects the patient experience during routine care by creating a coordinated registry network (CRN) that uses structured data capture and HL7 FHIR to efficiently extract, standardize, and exchange data from electronic health records and link registries and other data sources to cover a number of technologies in clinical areas unique to women.
|
|
FDA-NIH Joint Leadership Council
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
OD/OSP, NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/IMOD, OD/OER
|
Facilitates leadership-level development of mutual priorities between both Department of Health and Human Services (HHS) operating divisions.
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIMH
|
Food and Drug Administration (FDA) and National Institute of Mental Health (NIMH) representatives meet quarterly to discuss issues of mutual interest related to the development and clinical trials of pharmacologic therapeutic interventions.
|
|
Federal Consortium on the Substance Abusing Offender
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NIDA
|
Coordination of approximately a dozen agencies that work with substance abusing offenders. Staff meet by phone quarterly to provide updates on projects and initiatives at their agencies at the intersection of substance use and justice.
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, OASH
|
OD/DPCPSI/ONR, NHLBI, NIDDK, OD/DPCPSI
|
This Dietary Reference Intakes subcommittee reports to the Interagency Committee on Human Nutrition Research (ICHRN) to provide oversight on the process used to establish the Dietary Reference Intakes. These values serve as a basis for many federal nutrition programs and policies.
|